Search

everythinglearnresearchcommunity

for

Search:↓

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

People with Primary Cicatricial Alopecia have a higher risk of heart disease.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Women with PCOS have a higher risk of heart disease.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Lower testosterone levels may increase heart failure risk in older men.

Men with early-onset hair loss have more heart disease risk factors.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.